Hormonal therapy plus radiation increases survival in node-positive prostate cancer
the ONA take:
According to a new study published online in the Journal of the National Cancer Institute, researchers from the American Cancer Society and Massachusetts General Hospital Cancer Center in Boston have found that the addition of radiotherapy to hormonal therapy may improve survival in men with node-positive prostate cancer who are at significant risk of cancer-related death.
The study showed that approximately half of patients with node-positive prostate cancer in the United States who had not received combined radiation therapy and hormonal therapy and were therefore not receiving the treatment that could best inhibit tumor growth and improve survival.
"Our analysis of a large national database revealed that adding radiation therapy to androgen-deprivation therapy decreased the risk of death in these patients by 50 percent over five years," says Jason Efstathiou, MD, DPhil, of the MGH Cancer Center and Department of Radiation Oncology, senior author of the study.
Researchers found that more aggressive local management of prostate cancer that is limited to the pelvis can result in more durable disease control, limit cancer metastasis, and potentially cure some patients.
Addition of radiotherapy to hormonal therapy may improve survival in men with node-positive prostate cancer.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|